Literature DB >> 1330624

Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor.

J F Flood1, J E Morley, T H Lanthorn.   

Abstract

Glycine has been shown to modulate N-methyl-D-aspartate (NMDA) subclass of acidic amino acid receptors which have been implicated in learning and memory. We report that d-cycloserine (DCS) which has a high affinity for the glycine modulatory site in the NMDA receptor complex modulated memory processing in a dose-dependent manner. Mice were trained on a footshock avoidance task. Immediately after training DCS was administered (2.5 to 50 mg/kg s.c.). When retention was tested a week later, 20 mg/kg facilitated retention the best with lower and higher doses be less effective in weakly trained young mice. DCS also facilitated retention in 'senescence-accelerated mice' in which impairment of learning and memory increases with age. DCS had to be administered at higher doses to improve retention as impairment of learning and memory increased.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330624     DOI: 10.1016/0014-2999(92)90709-d

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  32 in total

Review 1.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

Authors:  Michael W Otto; M Alexandra Kredlow; Jasper A J Smits; Stefan G Hofmann; David F Tolin; Rianne A de Kleine; Agnes van Minnen; A Eden Evins; Mark H Pollack
Journal:  Biol Psychiatry       Date:  2015-09-25       Impact factor: 13.382

2.  Subtle effects of ketamine on memory when administered following stimulus presentation.

Authors:  David J LaPorte; Teresa A Blaxton; Tamara Michaelidis; Donald U Robertson; Martin A Weiler; Carol A Tamminga; Adrienne C Lahti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

3.  Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.

Authors:  Jacqueline Blundell; Cory A Blaiss; Mark R Etherton; Felipe Espinosa; Katsuhiko Tabuchi; Christopher Walz; Marc F Bolliger; Thomas C Südhof; Craig M Powell
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

4.  Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Authors:  Kevin K Ogden; Alpa Khatri; Stephen F Traynelis; Scott A Heldt
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

5.  Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.

Authors:  Kendra M Cherry; Eric J Lenze; Catherine E Lang
Journal:  J Neurophysiol       Date:  2014-03-26       Impact factor: 2.714

6.  d-cycloserine reverses the detrimental effects of stress on learning in females and enhances retention in males.

Authors:  Jaylyn Waddell; Elyse Mallimo; Tracey Shors
Journal:  Neurobiol Learn Mem       Date:  2009-08-08       Impact factor: 2.877

7.  Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.

Authors:  W Löscher; P Wlaź; C Rundfeldt; H Baran; D Hönack
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; K Matthew Lattal; Christopher L Cunningham
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

9.  D-cycloserine 24 and 48 hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathology.

Authors:  Vélvá M Combs; Heather D Crispell; Kelly L Drew
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

10.  Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.

Authors:  Donald C Goff; Corinne Cather; Jennifer D Gottlieb; A Eden Evins; Jared Walsh; Lisa Raeke; Michael W Otto; David Schoenfeld; Michael F Green
Journal:  Schizophr Res       Date:  2008-09-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.